Nurse caring for pregnant woman using NèoMotion device
Transforming Maternal-Fetal Care

Every Heartbeat.
Every Mother.
Everywhere.

NèoMotion is developing next-generation fetal monitoring technology that is intelligent, non-invasive, and accessible to every mother, in every setting.

Provisional application status with USPTO
Continuous MonitoringReal-time insights
Non-InvasiveSafe & comfortable
AI-PoweredSmart analytics
Connected CareAnywhere, anytime
The Global Impact

The Need is Urgent.
The Opportunity is Global.

Every day, mothers and babies could have better outcomes with earlier detection and actionable insights.

👩‍🍼
287,000+Maternal deaths every yearSource: WHO, 2023
2.0M+Stillbirths every yearSource: WHO, 2023
94%in low & lower-middle income countriesSource: WHO, 2023
1.7B+lack access to basic maternal careSources: WHO / UNICEF
Maternal & Newborn Health Challenges Worldwide
High Income Countries
Upper-Middle Income
Lower-Middle Income
Low Income Countries
Maternal Mortality Ratio (deaths per 100,000 live births)
12High Income
75Upper-Middle
330Lower-Middle
810Low Income
Sources: World Health Organization (WHO) and UNICEF public maternal/newborn health data.
Our Solution

Intelligent. Portable.
Designed for Every Setting.

NèoMotion empowers clinicians and expectant mothers with continuous insights into fetal and maternal well-being—at home, in clinics, and during care transitions.

Discover How It Works →
NèoMotion wearable device concept
Fetal Heart Rate MonitoringContinuous trend tracking with clinician-friendly views.
Fetal Movement DetectionActivity trend awareness for earlier risk recognition.
Maternal Vital SignsKey maternal indicators to support connected care.
Smart AlertsActionable notifications without exposing proprietary methods.
Secure & ConnectedData to mobile app and clinician dashboard.
Mission & Vision

Clinical-grade ambition, global-health urgency.

Our mission is to expand access to timely maternal-fetal insight through a comfortable, connected, scalable monitoring platform. We publicly communicate the problem, clinical value, and intended benefits while keeping internal engineering, algorithms, and implementation details confidential.

Maternal care and clinical support
Our Story • New in v21

Innovation Begins Where the Need Is Greatest

NèoMotion was not born in a research laboratory or a Silicon Valley incubator. It was born in the maternity wards of Chad, where our Founder & CEO, Dr. Bargo M. Yousif, witnessed the devastating consequences of limited access to basic maternal healthcare.

Too many mothers arrived without adequate antenatal care. Too many pregnancies progressed without continuous fetal monitoring. Too many preventable complications were recognized only after labor had already begun.

Behind every statistic was a mother, a newborn, and a family whose future changed forever. The problem was never a lack of dedicated healthcare professionals. The problem was access: access to affordable technology, timely clinical information, and tools that could help clinicians make better decisions before it was too late.

What if the world’s most accessible maternal monitoring technology was designed for the communities that need it most?

That question became the foundation of NèoMotion. Dr. Abubaker Hassan joined the mission as Co-Founder & Chief Operating Officer, bringing experience in pulmonary and critical care medicine, healthcare strategy, artificial intelligence, and international clinical operations.

Together, the founders set out to build technology capable of serving every healthcare environment—from rural clinics with limited resources to leading academic medical centers.

NèoMotion starts from the problem, not from the prestige of a startup ecosystem. Not every healthcare startup needs to begin in Silicon Valley. Some of the most important innovations can begin in Africa, built from firsthand understanding of urgent clinical need, and then scale to the whole world.

Our journey started in Africa. Our mission is global.

🇹🇩 ChadClinical observations in maternal care.
💡 The IdeaDesign around access, not privilege.
🤝 FoundersClinical partnership and global mission.
🇺🇸 IPUSPTO provisional application status.
🚀 NextClinical feedback, pilots, and scale.
Our Leadership

Built by clinicians. Driven by purpose.

A founder-led team combining frontline clinical insight, global health experience, and commercialization discipline.

Meet the Team →
Dr. Bargo M. Yousif

Dr. Bargo M. Yousif

Founder & CEO
  • Physician leader
  • Global health innovator
  • Focused on maternal and newborn outcomes

LinkedIn →

Dr. Abubaker Hassan

Dr. Abubaker Hassan

Co-Founder & COO
  • Pulmonary & Critical Care Physician
  • Harvard Medical School AI in Healthcare alumnus
  • Clinical strategy, operations, and partnerships

LinkedIn →

Why NèoMotion

Purpose-driven innovation with global commercial potential.

NèoMotion sits at the intersection of maternal health, responsible AI, remote monitoring, and global access. We are building for clinical value first, while preserving a scalable business pathway.

Clinical Insight

Founded by physicians with firsthand exposure to urgent maternal-health gaps.

🌍
Global Vision

Designed for every setting, from rural clinics to academic medical centers.

🤖
Responsible AI

Decision support for clinicians, not replacement of clinical judgment.

📈
Scalable Impact

A mission-aligned model with broad maternal-health relevance.

🔒
Protected IP

Public messaging stays high-level while proprietary details remain confidential.

Roadmap

From concept to clinical validation.

2026MVP & IP

Prototype iteration, provisional application, advisor recruitment.

2027Clinical Feedback

Obstetric advisors, usability testing, pilot conversations.

2028Regulatory Pathway

Quality system, safety testing, regulatory planning.

2029Scale

Strategic partnerships across GCC, Africa, and North America.

Investors & Partners

Backed by a global partnership vision.

NèoMotion is preparing for conversations with mission-aligned investors, accelerators, clinical systems, research institutions, and global health organizations.

Prospective Investor & Accelerator Network
QSTP
Techstars
Y Combinator
Antler
Village Capital
Real Ventures
Prospective Strategic & Clinical Partners
🏥
Hospitals & Health Systems
Pilot sites, care pathways, and clinician feedback.
🎓
Universities & Research Institutions
Maternal-fetal health research and validation planning.
🌍
NGOs & Global Health Organizations
Access expansion in underserved communities.
Investors & Partners

Secure Investor & Partner Portal

Confidential materials for qualified investors, clinical partners, incubators, and research collaborators. Public pages provide only high-level, non-confidential information.

Investment Thesis
Large unmet need, mission-driven founders, AI-enabled monitoring, and scalable global-health opportunity.
Collaboration Focus
Clinical feedback, pilot planning, research partnerships, global access, and strategic commercialization.
IP Protection
Detailed engineering, internal architecture, algorithms, claims, and manufacturing assumptions remain private.
Access
Demo password: NeoMotion2026. Formal access should be approved by the founders.

Enter Portal Password

Need access? Contact the founders.

Note: this public website intentionally avoids confidential technical implementation details to protect NèoMotion’s intellectual property.

Investor Data Room

High-level, non-confidential materials for qualified partners. Detailed engineering, algorithms, architecture, manufacturing assumptions, and patent claims remain private.

Executive SummaryMission, product vision, clinical need, and partnership thesis.
Pitch DeckInvestor-facing overview prepared for early-stage discussions.
Company ProfileLeadership, positioning, operating model, and contact information.
Patent StatusProvisional application status and high-level IP summary only.
Market OpportunityMaternal-fetal monitoring need, global access gap, and go-to-market logic.
Clinical Validation PlanAdvisor recruitment, usability feedback, pilot planning, and evidence pathway.

Partner With Us to Transform Maternal-Fetal Care Worldwide

We welcome conversations with investors, clinical partners, incubators, and global health organizations.

Contact Us →